[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.238.28. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
June 15, 2011

Omitted Disclosure in: Short-term Use of Unopposed Estrogen: A Balance of Inferred Risks and Benefits

JAMA. 2011;305(23):2418. doi:10.1001/jama.2011.792

Omitted Disclosure: In the Editorial entitled “Short-term Use of Unopposed Estrogen: A Balance of Inferred Risks and Benefits,” published in the April 6, 2011, issue of JAMA (2011;305[13]:1354-1355), in the Conflict of Interest Disclosures section, it should read, “Dr Colditz reported that money was paid to his institution (Washington University School of Medicine) by Littlepage Booth for his expert testimony regarding plaintiff-attorney group interpretation of epidemiological data on hormones and breast cancer.” Dr Colditz reported this information to JAMA on his completed ICMJE Disclosure Form, but this disclosure was erroneously omitted from the published editorial. This editorial has been corrected online.

×